Biocept Inc
Change company Symbol lookup
Select an option...
BIOC Biocept Inc
$SPMDCCBSA S&P 400 - Cable & Satellite(Sub Ind)
BAC Bank of America Corp
SLRC Solar Capital Ltd
ORTX Orchard Therapeutics PLC
TOO-E Teekay Offshore Partners LP
TBT ProShares UltraShort 20+ Year Treasury
ASDTX AllianzGI Short Duration High Income Fund
ETR Entergy Corp
ET Energy Transfer LP
Go

Health Care : Biotechnology | Small Cap ValueCompany profile

Biocept, Inc. is an early commercial-stage molecular oncology diagnostics company. The Company develops and commercializes circulating tumor cell (CTC) and circulating tumor deoxyribonucleic acid (ctDNA), assays utilizing a standard blood sample, or liquid biopsy. The Company's Target-Selector offering is based on an internally developed, microfluidics-based CTC capture and analysis platform, with enabling features that change how CTC testing can be used by clinicians by providing biomarker detection and monitoring requiring only a standard blood sample. The ctDNA technology enables mutation detection and is applicable to nucleic acid from CTCs or other sample types, such as blood plasma. The Company commercializes its Target-Selector assays for a range of solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), gastric cancer, colorectal cancer, prostate cancer and melanoma.

Closing Price
$1.05
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
3,345,436
0
  • Prev Close
    1.05
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    3.3M
  • Last (time)
    4:00p ET 03/21/19
  • Last (size)
    1
  • 52-Wk Range
    0.658 - 12.15
    LowHigh
  • (07/13/18 - 12/17/18)
    59.57%
  • 189.4%
  • Market Cap
    4.3M
  • Shares Outstanding
    4.1M
  • -10.69
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 2.9
  • 13.32
  • (% of float 02/28/19)
    4.20

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.